Michael Davis

Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The closing of the transaction, which is expected in the third quarter…

Davis Polk is advising Cooper Gay Swett & Crawford Ltd. in connection with the $500 million acquisition of CGSC North America Holdings Corporation (“Swett & Crawford”) by BB&T…

Davis Polk advised Metalmark Capital in connection with its majority investment in WorldStrides. Under the terms of the sale and merger agreement, The Carlyle Group and its co-investors…

Davis Polk is advising Lightyear Capital LLC and Clarion Partners Holdings LLC on the sale of Clarion Partners to Legg Mason, Inc. The transaction is subject to customary regulatory and…

Davis Polk is advising Biotie Therapies Corp. in connection with its combination agreement with Acorda Therapeutics, Inc. where Acorda will make a public tender offer in Finland and the…

Davis Polk is advising Charles River Laboratories International, Inc. on its acquisition of WIL Research for approximately $585 million. The transaction, which is expected to close early in…

Davis Polk advised Hotel Urbano in connection with its strategic partnership with The Priceline Group. The partnership consists of a $60 million minority investment by Priceline and a…

Davis Polk advised Brinker International, Inc. in connection with its $106.5 million acquisition of Pepper Dining Holding Corp., a franchisee of 103 Chili’s Grill & Bar restaurants…

Davis Polk is advising Warner Chilcott plc in connection with its approximately $8.5 billion acquisition by Actavis, Inc. in a stock-for-stock transaction. The transaction is expected to…

Davis Polk is advising H. J. Heinz Company on its $28 billion acquisition by an investment consortium consisting of Berkshire Hathaway and 3G Capital, the largest transaction ever in the…